Talphera
$0.8
65
-$0.02-1.85% Tuesday 20:00
Statistics
Day High
0.84
Day Low
0.79
52W High
1.46
52W Low
0.39
Volume
123,740
Avg. Volume
-
Mkt Cap
37.29M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
19AugExpected
Expected EPS
-0.06
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-26.01MNet Income
Analyst Ratings
3Average Price Target
The highest estimate is 3.00.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TLPH. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap302.33B
Pfizer
PFE
Mkt Cap147.62B
Bristol-Myers Squibb
BMY
Mkt Cap121.42B
Gilead Sciences
GILD
Mkt Cap166.82B
Abbvie
ABBV
Mkt Cap381.1B
AMGEN
AMGN
Mkt Cap183.12B
Johnson & Johnson
JNJ
Mkt Cap564.11B
Novartis
NVS
Mkt Cap290.05B
Roche
RHHBY
Mkt Cap343.56B
Astrazeneca
AZN
Mkt Cap290.06B
About
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including COVID-19, disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. Talphera, Inc. was incorporated in 2005 and is headquartered in San Mateo, California.
Show more...
CEO
Mr. Vincent J. Angotti
Employees
13
Country
United States
ISIN
US00444T2096
Listings
0 Comments
Share your thoughts
FAQ
What is Talphera stock price today?▼
The current price of TLPH is $0.8 USD — it has decreased by -1.85% in the past 24 hours. Watch Talphera stock price performance more closely on the chart.
What is Talphera stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Talphera stocks are traded under the ticker TLPH.
Is Talphera stock price growing?▼
TLPH stock has fallen by -2.77% compared to the previous week, the month change is a +7.35% rise, over the last year Talphera has showed a +59.46% increase.
What is Talphera market cap?▼
Today Talphera has the market capitalization of 37.29M
When is the next Talphera earnings date?▼
Talphera is going to release the next earnings report on August 19, 2026.
What were Talphera earnings last quarter?▼
TLPH earnings for the last quarter are -0.04 USD per share, whereas the estimation was -0.07 USD resulting in a +40% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Talphera revenue for the last year?▼
Talphera revenue for the last year amounts to 0 USD.
What is Talphera net income for the last year?▼
TLPH net income for the last year is -26.01M USD.
How many employees does Talphera have?▼
As of May 27, 2026, the company has 13 employees.
In which sector is Talphera located?▼
Talphera operates in the Health & Wellness sector.
When did Talphera complete a stock split?▼
The last stock split for Talphera was on October 26, 2022 with a ratio of 1:20.
Where is Talphera headquartered?▼
Talphera is headquartered in San Mateo, United States.